Recombinant Uncharacterized protein in hblA 3'region

Shipped with Ice Packs
In Stock

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, please specify your format preference during order placement for customized preparation.
Lead Time
Delivery times vary depending on the purchasing method and location. Please consult your local distributor for precise delivery estimates.
Note: Our proteins are shipped with standard blue ice packs. Dry ice shipping requires advance notification and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to settle the contents. Reconstitute the protein in sterile deionized water to a concentration of 0.1-1.0 mg/mL. We recommend adding 5-50% glycerol (final concentration) and aliquoting for long-term storage at -20°C/-80°C. Our standard glycerol concentration is 50%, provided as a guideline.
Shelf Life
Shelf life depends on various factors including storage conditions, buffer composition, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized forms have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquoting is recommended for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing.
The tag type is determined during the production process. If you require a specific tag, please inform us, and we will prioritize its development.
Synonyms
Uncharacterized protein in hblA 3'region; Fragment
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
23-158
Protein Length
Full Length of Mature Protein
Species
Bacillus cereus
Target Protein Sequence
VIPIETFAIEIQQTNTENRSLSANEEQMKKALQDAGLFVKAMNEYSYLLIHNPDVSFEGI TINGNTDLPSKIVQDQKNARAHAVTWNTHVKKQLLDTLTGIIEYDTKFENHYETLVEAIN TGNGDTLKKGITDLQG
Uniprot No.

Target Background

Subcellular Location
Cell membrane.

Q&A

What is the uncharacterized protein in hblA 3'region and what is its relationship to the Hbl toxin complex?

The uncharacterized protein in hblA 3'region, also designated as Hbl B', is encoded by the hblB gene located downstream of the hblCDA operon in Bacillus cereus. This protein is part of the broader haemolysin BL (Hbl) enterotoxin complex. While the hblC, hblD, and hblA genes encode the components Hbl L2, L1, and B respectively, the hblB gene encodes the Hbl B' protein, which has been determined to have a distinct regulatory function within the Hbl enterotoxin mechanism . Research has confirmed that the hblB gene is expressed and the Hbl B' protein is secreted by nearly all analyzed B. cereus strains, indicating its biological importance in these bacterial systems .

What are the structural and biochemical properties of the recombinant Hbl B' protein?

The recombinant Hbl B' protein has the following properties:

  • Amino Acid Sequence: VIPIETFAIEIQQTNTENRSLSANEEQMKKALQDAGLFVKAMNEYSYLLIHNPDVSFEGIITINGNTDLPSKIVQDQKNARAHAVTWNTHVKKQLLDTLTGIIEYDTKFENHYETLVEAINTGNGDTLKKGITDLQG

  • Expression Region: 23-158

  • UniProt Identifier: Q45104

  • Species Origin: Bacillus cereus

  • Structural Similarity: The Hbl components, including Hbl B', show structural similarity to hemolysin E (HlyE; ClyA) proteins

  • Functional Domain: Contains a region structurally important for interaction with Hbl L1 component

When working with this protein, optimal storage conditions include using a Tris-based buffer with 50% glycerol at -20°C, or -80°C for extended storage. Working aliquots can be stored at 4°C for up to one week, though repeated freezing and thawing should be avoided to maintain protein integrity .

How can researchers differentiate between Hbl B' and other components of the Hbl complex?

Researchers can differentiate Hbl B' from other components of the Hbl complex using the following methodological approaches:

  • Immunological Methods: Use of monoclonal antibody 11A5, which has been specifically developed for Hbl B' detection in B. cereus culture supernatants

  • Genetic Analysis: PCR amplification of the 3' part of the hblB gene using specific primers (such as hblB-3'-fw: CATAACGCATACACTTTTGAAATAAAG and hblB-3'-rev: CCGCAAATTCATCATTTGGATTG) that target regions distinct from hblA

  • Protein Expression Profiles: Analysis of secreted proteins in culture supernatants using SDS-PAGE followed by immunoblotting with specific antibodies

  • Functional Assays: Conducting cytotoxicity or hemolysis assays using recombinant components individually and in combinations to observe differential effects

What experimental design considerations are important when studying Hbl B' interactions with other Hbl components?

When designing experiments to study Hbl B' interactions with other Hbl components, researchers should consider implementing a factorial design approach to systematically evaluate variable interactions. Based on established research methodologies:

  • Factor Identification: The primary factors to consider include:

    • Protein concentrations (typically using 1.5 pmol/μl stock solutions)

    • Component combinations (L2, L1, B, B', and truncated variants)

    • Incubation time and temperature

    • Cell or tissue type for functional assays

  • Experimental Design Structure: A full factorial design allows for testing all possible combinations of factors. For example, a 3×2 design could include:

    • Three concentration levels of Hbl B' (low, medium, high)

    • Two different cell lines for toxicity assessment

  • Controls and Variables:

    • Positive controls: Known active combinations of Hbl components

    • Negative controls: Buffer-only or irrelevant protein preparations

    • Dependent variables: Cytotoxicity measurements, hemolysis rates, or protein-protein interaction metrics

Table 1: Example Factorial Design for Hbl B' Interaction Studies

Experimental ConditionHbl L2Hbl L1Hbl BHbl B'Cell Type
1+++-Vero
2++++Vero
3++-+Vero
4+-++Vero
5-+++Vero
6+++-CaCo-2
7++++CaCo-2
8++-+CaCo-2
9+-++CaCo-2
10-+++CaCo-2

This design allows for systematic assessment of component interactions while controlling for cell type variability .

What methodological approaches should be used for cloning and expressing recombinant Hbl B'?

The cloning and expression of recombinant Hbl B' should follow these methodological steps:

  • Gene Amplification:

    • PCR amplify the hblB gene from B. cereus genomic DNA

    • Use specific primers that incorporate appropriate restriction enzyme sites for directional cloning

    • Ensure the 3' region of hblB that differs from hblA is specifically targeted

  • Cloning Strategy:

    • Clone the amplified gene into an expression vector such as pASK-IBA5plus

    • This approach adds an N-terminal strep-tag to facilitate purification

    • For functional studies, consider creating truncated variants (e.g., removing C-terminal 91 amino acids)

  • Expression Optimization:

    • Transform the construct into an appropriate E. coli strain

    • Optimize expression conditions including IPTG concentration, temperature, and duration

    • Monitor expression using SDS-PAGE and Western blotting

  • Purification Protocol:

    • Lyse cells under native conditions using appropriate buffer systems

    • Purify using affinity chromatography based on the incorporated tag

    • Consider additional purification steps such as ion exchange or size exclusion chromatography

    • Use Tris-based buffer with 50% glycerol for final storage

  • Quality Control:

    • Verify protein identity using mass spectrometry

    • Assess purity using SDS-PAGE

    • Confirm activity using functional assays

This methodological approach ensures production of high-quality recombinant protein suitable for subsequent functional and structural studies .

How should researchers design cytotoxicity assays to evaluate Hbl B' function?

When designing cytotoxicity assays to evaluate Hbl B' function, researchers should implement the following methodological approach:

  • Reagent Preparation:

    • Prepare 1.5 pmol/μl stock solutions of recombinant Hbl components (L2, L1, B, B', and truncated variants)

    • Use appropriate buffers that maintain protein stability

    • Pre-mix components in defined ratios before addition to cells

  • Assay Selection:

    • WST-1 Bioassay: Measures metabolic activity of viable cells through enzymatic conversion of tetrazolium salt

    • Propidium Iodide (PI) Influx Test: Assesses membrane integrity and pore formation

    • Both assays provide complementary information about cytotoxic effects

  • Experimental Setup:

    • Use appropriate cell lines (e.g., Vero, CaCo-2)

    • Conduct dilution series (typically 1:40 dilutions) to establish dose-response relationships

    • Include appropriate controls (untreated cells, individual components, known cytotoxic agents)

    • Run replicates (minimum n=3) for statistical validity

  • Data Collection Protocol:

    • Establish consistent timepoints for measurements (e.g., 1, 4, and 24 hours)

    • For WST-1, measure absorbance at appropriate wavelengths

    • For PI influx, use fluorescence microscopy or flow cytometry

    • Document morphological changes using phase-contrast microscopy

  • Data Analysis:

    • Calculate relative cytotoxicity compared to controls

    • Generate dose-response curves

    • Apply statistical tests appropriate for the experimental design

    • Consider modeling approaches to quantify component interactions

This comprehensive approach ensures reliable assessment of Hbl B' function in the context of the complete Hbl toxin complex.

What statistical approaches are recommended for analyzing Hbl B' cytotoxicity data?

When analyzing cytotoxicity data involving Hbl B', researchers should employ a structured statistical framework:

  • Exploratory Data Analysis:

    • Generate descriptive statistics (mean, median, standard deviation) for cytotoxicity measurements

    • Create visualization plots (dose-response curves, box plots) to identify patterns

    • Check for outliers and data distribution characteristics

  • Statistical Testing Framework:

    • For comparing cytotoxicity between different component combinations:

      • ANOVA followed by post-hoc tests (e.g., Tukey's HSD) for multiple comparisons

      • t-tests for direct comparisons between two specific conditions

    • For dose-response relationships:

      • Regression analysis to determine EC50 values

      • Curve fitting to appropriate models (e.g., Hill equation)

  • Interaction Analysis:

    • Implement factorial ANOVA to assess interaction effects between Hbl components

    • Consider mixed-effects models if incorporating multiple cell lines or time points

    • Analyze synergistic or antagonistic effects using isobologram approaches

  • Nonlinear Analysis:

    • Apply nonlinear modeling when dose-response curves show complex patterns

    • Consider harmonics and subharmonics in time-dependent assays

    • Implement appropriate transformations to linearize data when necessary

How can researchers integrate binding data with functional outcomes to understand Hbl B' regulatory mechanisms?

Integrating binding data with functional outcomes requires a comprehensive analytical approach:

  • Data Integration Framework:

    • Compile direct binding data (e.g., from co-immunoprecipitation, surface plasmon resonance)

    • Collate functional outcomes (cytotoxicity, hemolysis, pore formation metrics)

    • Normalize datasets to enable direct comparisons

    • Create relational databases to facilitate integration

  • Correlation Analysis:

    • Calculate correlation coefficients between binding parameters and functional outcomes

    • Generate scatter plots to visualize relationships

    • Apply regression analysis to quantify relationships

    • Consider multivariate analyses when multiple factors are involved

  • Modeling Approaches:

    • Develop mathematical models describing the relationship:
      Functional Outcome=f(Binding Parameters)+Error\text{Functional Outcome} = f(\text{Binding Parameters}) + \text{Error}

    • Test multiple model structures to identify best fit

    • Validate models with independent datasets

    • Incorporate time-dependent variables when appropriate

  • Network Analysis:

    • Construct interaction networks representing component relationships

    • Identify key nodes and edges that influence regulatory mechanisms

    • Apply perturbation analyses to test model robustness

    • Utilize systems biology approaches for complex interactions

Table 2: Example Data Integration Framework for Hbl B' Analysis

Binding ParameterMeasurement TechniqueFunctional OutcomeAnalysis Method
Hbl B'-L1 affinitySurface plasmon resonanceCytotoxicity (WST-1)Pearson correlation
Binding kineticsBiolayer interferometryPore formation (PI influx)Regression analysis
Complex stabilitySize exclusion chromatographyHemolysis rateTime-series analysis
Binding site mappingMutagenesis studiesStructural changesStructure-function correlation

This integration approach enables a comprehensive understanding of how Hbl B' molecular interactions translate to functional outcomes in biological systems .

How do strain variations in hblB affect the function and expression of Hbl B' protein?

Analysis of strain variations in hblB and their impact on Hbl B' function requires a nuanced methodological approach:

  • Comparative Genomic Analysis:

    • Sequence hblB genes from multiple B. cereus strains

    • Identify single nucleotide polymorphisms (SNPs) and structural variations

    • Conduct phylogenetic analysis to trace evolutionary relationships

    • Correlate genetic variations with phenotypic differences

  • Expression Profiling:

    • Quantify hblB transcript levels across strains using RT-qPCR

    • Assess protein expression using Western blotting with monoclonal antibody 11A5

    • Evaluate secretion efficiency in culture supernatants

    • Analyze co-expression patterns with other Hbl components

  • Structure-Function Analysis:

    • Clone variant hblB genes from different strains

    • Express and purify recombinant proteins

    • Assess functional parameters including:

      • Binding affinity to Hbl L1

      • Regulatory effects on cytotoxicity

      • Hemolytic activity modulation

    • Correlate structural variations with functional differences

  • Systems Biology Approach:

    • Integrate genomic, transcriptomic, and proteomic data

    • Construct regulatory networks involving hblB and related genes

    • Model strain-specific differences in toxin production and activity

    • Apply machine learning algorithms to identify predictive markers of virulence

Research indicates that while the hblB gene is present in most B. cereus strains, variations in expression levels and protein sequence can significantly impact the regulation of Hbl toxin activity, potentially contributing to differences in virulence between strains .

What are the methodological challenges in studying the interaction between Hbl B' and cell surface receptors?

Investigating the interaction between Hbl B' and cell surface receptors presents several methodological challenges that require sophisticated approaches:

  • Receptor Identification Strategies:

    • Cross-linking coupled with mass spectrometry:

      • Use photo-activatable or chemical cross-linkers to capture transient interactions

      • Identify cross-linked complexes using tandem mass spectrometry

      • Validate candidate receptors through co-localization studies

    • Affinity purification approaches:

      • Use tagged Hbl B' as bait to pull down interacting membrane proteins

      • Implement stringent washing conditions to reduce false positives

      • Confirm specificity through competition assays

  • Binding Kinetics Characterization:

    • Technical Challenges:

      • Membrane proteins often denature when removed from their lipid environment

      • Maintaining protein-lipid interactions during purification

      • Accounting for the influence of membrane microdomains

    • Methodological Solutions:

      • Use nanodiscs or liposomes to maintain lipid environment

      • Implement single-molecule techniques for heterogeneous binding studies

      • Apply total internal reflection fluorescence (TIRF) microscopy to observe binding in real-time

  • Functional Validation Approaches:

    • CRISPR-Cas9 gene editing:

      • Knockout candidate receptors to assess functional impact

      • Create precise mutations in binding interfaces

      • Develop cell line panels with defined receptor expression

    • Receptor blocking strategies:

      • Use antibodies or aptamers to block specific receptors

      • Develop competitive inhibitors based on interaction interfaces

      • Apply siRNA knockdown for transient receptor depletion

  • Computational Modeling Considerations:

    • Develop molecular docking simulations incorporating membrane dynamics

    • Account for conformational changes upon binding

    • Model the energetics of protein-membrane interactions

    • Integrate experimental data with in silico predictions

Recent discoveries of specific Hbl target structures like LITAF and CDIP1 on cell surfaces have advanced understanding of Hbl binding mechanisms, but the specific role of Hbl B' in these interactions remains an active area of investigation requiring integrated experimental approaches .

How can advanced data analysis techniques improve understanding of Hbl B' function in the context of host-pathogen interactions?

Advanced data analysis techniques can significantly enhance our understanding of Hbl B' function in host-pathogen interactions through the following methodological approaches:

  • Multi-omics Data Integration:

    • Methodological Framework:

      • Integrate transcriptomics, proteomics, and metabolomics data

      • Apply dimensional reduction techniques (PCA, t-SNE) to identify patterns

      • Implement network analysis to identify key interaction hubs

      • Use machine learning algorithms to classify response patterns

    • Practical Implementation:

      • Collect data across multiple timepoints post-exposure

      • Include various host cell types and bacterial strains

      • Normalize datasets appropriately before integration

      • Validate findings using targeted experimental approaches

  • Temporal Analysis of Host Response:

    • Time-Series Analysis Techniques:

      • Apply dynamic time warping to align response patterns

      • Use hidden Markov models to identify state transitions

      • Implement Gaussian process regression for continuous modeling

      • Develop differential equation models for mechanistic understanding

    • Visualization Methods:

      • Create heat maps showing temporal expression patterns

      • Generate trajectory plots in reduced dimensional space

      • Develop interactive visualizations for exploring multi-dimensional data

  • Systems-Level Modeling:

    • Model Types and Applications:

      • Ordinary differential equation (ODE) models for concentration dynamics

      • Agent-based models for cellular interaction simulations

      • Bayesian networks for causal relationship inference

      • Constraint-based models for metabolic response analysis

    • Model Validation Framework:

      • Cross-validation with independent datasets

      • Sensitivity analysis to identify robust parameters

      • Perturbation studies to test model predictions

      • Iterative refinement based on experimental feedback

  • Computational Analysis of Structure-Function Relationships:

    • Structural Bioinformatics Approaches:

      • Homology modeling of Hbl B' structure

      • Molecular dynamics simulations of protein-protein interactions

      • Interface analysis to identify critical binding residues

      • Virtual screening for potential inhibitors

    • Functional Prediction Methods:

      • Machine learning algorithms to predict toxicity from sequence

      • Statistical coupling analysis to identify co-evolving residues

      • Network analysis of structure-function relationships

By implementing these advanced analytical techniques, researchers can move beyond correlative observations to develop mechanistic models that explain how Hbl B' contributes to the complex dynamics of host-pathogen interactions in B. cereus infections .

What emerging technologies could advance our understanding of Hbl B' structure and function?

Several emerging technologies hold significant promise for advancing our understanding of Hbl B' structure and function:

  • Structural Biology Advancements:

    • Cryo-electron microscopy (Cryo-EM):

      • Enables visualization of Hbl complexes in near-native states

      • Allows structural analysis without crystallization

      • Can capture different conformational states

      • Methodology involves vitrification of samples, image acquisition at various angles, and computational reconstruction of 3D structures

    • Integrative structural biology approaches:

      • Combine X-ray crystallography, NMR, SAXS, and computational modeling

      • Provide comprehensive structural insights across different resolution scales

      • Enable visualization of dynamic protein assemblies

  • Advanced Imaging Techniques:

    • Super-resolution microscopy:

      • Tracks Hbl B' localization during pore formation with nanometer precision

      • Techniques such as STORM, PALM, or STED overcome diffraction limits

      • Can visualize toxin assembly on cell membranes in real-time

    • Correlative light and electron microscopy (CLEM):

      • Bridges the gap between functional fluorescence imaging and ultrastructural analysis

      • Enables tracking of specific molecules in the context of cellular ultrastructure

  • Single-Molecule Biophysics:

    • Optical tweezers and magnetic tweezers:

      • Measure forces and conformational changes during protein-protein interactions

      • Can assess binding kinetics at the single-molecule level

      • Provide insights into mechanical aspects of pore formation

    • Single-molecule FRET:

      • Monitors conformational dynamics of Hbl components during assembly

      • Reveals transient intermediate states otherwise difficult to capture

  • Artificial Intelligence and Machine Learning Applications:

    • Deep learning for structure prediction:

      • AlphaFold and similar algorithms can predict protein structures with high accuracy

      • Enables structural analysis even when experimental determination is challenging

      • Facilitates the identification of functional domains and binding interfaces

    • AI-driven experimental design:

      • Optimizes experimental conditions based on previous results

      • Identifies most informative experiments to resolve specific questions

      • Reduces experimental space to explore through intelligent sampling

These technologies, when applied systematically to the study of Hbl B', could revolutionize our understanding of its structural arrangements, molecular interactions, and functional mechanisms in the context of bacterial pathogenesis .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.